Prelude Therapeutics Inc (PRLD)

Last Year

16-May-23 -- 15-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

8

0

5

+1

0

+2

0

+3

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
24-May-23 5:07 PM View:	22-May-23 Private Purchase $5.00M	Bonita David P Director 10% Owner		Prelude Therapeutics Inc - PRLD	9% 9.78M to 10.65M	0	0	--	--	Show Txns Hide Txns

24-May-23 5:09 PM View:	22-May-23 Private Purchase Duplicate $5.00M	Orbimed Advisors LLC Director 10% Owner		Prelude Therapeutics Inc - PRLD	9% 9.78M to 10.65M	0	0	--	--	Show Txns Hide Txns

25-May-23 4:05 PM View:	23-May-23 Private Purchase $27.50K	Chardonnet Laurent Chief Financial Officer		Prelude Therapeutics Inc - PRLD	13% 37.16K to 42.16K	0	0	--	--	Show Txns Hide Txns

26-May-23 4:20 PM View:	25-May-23 Purchase $4.78K	Vaddi Krishna CEO Director		Prelude Therapeutics Inc - PRLD	1% 2.7M to 2.72M	0	0	--	--	Show Txns Hide Txns

08-Apr-24 4:11 PM View:	04-Apr-24 Payment of Exercise ($15.86K)	Huang Jane President, CMO		Prelude Therapeutics Inc - PRLD	112% 24.22K to 51.29K	0	0	--	--	Show Txns Hide Txns

25-May-23 4:07 PM View:	24-May-23 Private Purchase $12.94K	Lim Bryant David Chief Legal Officer, Corp Sec.		Prelude Therapeutics Inc - PRLD	100% 0 to 2.4K	0	0	--	--	Show Txns Hide Txns